Skip to main content


Log in

Adherence to STIKO recommendations in patients with pulmonary disease in southeast Germany

  • Brief Report
  • Published:
Infection Aims and scope Submit manuscript



Vaccinations are among the most effective preventative healthcare measures. The aim of this cross-sectional study was to evaluate the adherence of adults with pre-existing pulmonary conditions to the national vaccination schedule and to identify reasons for poor adherence.


All patients with an appointment at Donaustauf hospital between October 2019 and April 2020 were asked to bring their vaccination certificates for evaluation and to compete a questionnaire. To determine the adherence vaccination certificates and patients’ comorbidities were correlated with the national recommendations of the German Standing Committee on Vaccination (STIKO).


571 (65.6%) of all patients believed that their vaccination status was up-to-date. An appropriate vaccination status according to national recommendations (STIKO) was documented as follows: tetanus 56.4% (375/665), diphtheria 43.2% (292/676), poliomyelitis 28.5% (189/662), tick-borne encephalitis 45.4% (300/659), hepatitis A 31.0% (18/58), hepatitis B 34.6% (27/78), shingles 1.2% (6/489), influenza 21.0% (125/596, season 2019/2020), measles 38.3% (31/81), rubella 33.3% (7/21), pneumococcal disease 29.5% (175/593), pertussis 54.2% (365/674) and haemophilus influenza type b 100% (1/1). Adherence to rabies (0/2), varicella (0/28), meningococcal type ACWY (0/36) and type b (0/36) was 0%. 72% of patients would follow a physician’s recommendation to get vaccinated.


Adherence to STIKO recommendations was poor. However, patients are willing to follow a physician’s recommendation for vaccination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others


  1. Rieck T, Feig M, Wichmann O, Siedler A. Impfstatus der Kinder und Jugendlichen in Deutschland, STIKO: Influenzaimpfungen in der COVID-19-Pandemie. Epidemiologisches Bulletin. 2020:28–30.

  2. Elam-Evans LD, Yankey D, Singleton JA, Sterrett N, Markowitz LE, Williams CL, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69:1109–16.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Diallo D, Santal C, Lagrée M, Martinot A, Dubos F. Vaccination coverage of children with chronic diseases is inadequate especially for specifically recommended vaccines. Acta Paediatr. 2020;109:2677–84.

    Article  PubMed  Google Scholar 

  4. Rieck T, Neufeind J, Feig M, Siedler A, Wichmann O. Impfquoten bei Erwachsenen in Deutschland: Aktuelles aus der KV-Impfsurveillance und der Onlinebefragung von Krankenhauspersonal. Epidemiologisches Bulletin. 2019:457–72.

  5. Kwetkat A, Lehmann T, Weinberger S, Schelling J. Analyse der Impfdaten von 60-Jährigen und Älteren aus Bayern und Thüringen. Z Gerontol Geriatr. 2016;49:126–31.

    Article  PubMed  Google Scholar 

  6. Mohr A, Plentz A, Sieroslawski A, Pezenburg F, Pfeifer M, Salzberger B, Hitzenbichler F. Use of pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany. Respir Med. 2020;174: 106207.

    Article  PubMed  Google Scholar 

  7. RKI. Stellungnahme der Ständigen Impfkommission (STIKO) beim RKI: Bestätigung der aktuellen STIKO-Empfehlungen zur Pneumokokken-Impfung während der Pandemie und Handlungshinweise bei eingeschränkter Lieferbarkeit. Epidemiologisches Bulletin. 2020:27–30.

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Arno Mohr.

Ethics declarations

Conflict of interest

A. Mohr: travel grants from Gilead Sciences. A. Plentz: lecture fee from Pfizer. M. Pfeifer: grants from Boehringer Ing., Astra Zeneca, Glaxo SKB, Novartis and Gilead Sciences. B. Salzberger: advisory boards Sanofi u. GSK. F. Hitzenbichler: travel grants from Gilead Sciences, lecture fees from MSD.

Ethical approval

The study has been approved by the local ethics committee and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All specific national laws have been observed.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 16 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohr, A., Plentz, A., Sieroslawski, A. et al. Adherence to STIKO recommendations in patients with pulmonary disease in southeast Germany. Infection 49, 1319–1323 (2021).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: